Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabrielle Becher

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Travel Medicine and Infectious Disease|September 7, 2012
Erythema multiforme and Malarone(®)Gabrielle Becher, Grant Wylie
Contact Dermatitis|July 13, 2011
Action spectrum for etofenamate photoallergic contact dermatitisAlastair Kerr, Gabrielle Becher, Sally Ibbotson, et al.
Skin Health and Disease|June 7, 2024
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panelJonathan N Barker, Gabrielle Becher, David A Burden, et al.
JAMA Dermatology|July 6, 2022
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With PsoriasisZenas Z N Yiu, Gabrielle Becher, Brian Kirby, et al.
Dermatology and Therapy|September 8, 2022
A Retrospective Real-World Study of the Effectiveness and Tolerability of Tildrakizumab in UK Adults with Moderate-to-Severe Chronic Plaque PsoriasisGabrielle Becher, Sophia Conner, Jennifer A Ingram, et al.
JAMA Dermatology|September 19, 2019
Association of Serum Ustekinumab Levels With Clinical Response in PsoriasisTeresa Tsakok, Nina Wilson, Nick Dand, et al.
Clinical and Translational Science|January 30, 2020
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Nick Dand, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasisNick Dand, Michael Duckworth, David Baudry, et al.
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Travel Medicine and Infectious Disease|September 7, 2012
Erythema multiforme and Malarone(®)Gabrielle Becher, Grant Wylie
Contact Dermatitis|July 13, 2011
Action spectrum for etofenamate photoallergic contact dermatitisAlastair Kerr, Gabrielle Becher, Sally Ibbotson, et al.
Skin Health and Disease|June 7, 2024
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panelJonathan N Barker, Gabrielle Becher, David A Burden, et al.
JAMA Dermatology|July 6, 2022
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With PsoriasisZenas Z N Yiu, Gabrielle Becher, Brian Kirby, et al.
Dermatology and Therapy|September 8, 2022
A Retrospective Real-World Study of the Effectiveness and Tolerability of Tildrakizumab in UK Adults with Moderate-to-Severe Chronic Plaque PsoriasisGabrielle Becher, Sophia Conner, Jennifer A Ingram, et al.
JAMA Dermatology|September 19, 2019
Association of Serum Ustekinumab Levels With Clinical Response in PsoriasisTeresa Tsakok, Nina Wilson, Nick Dand, et al.
Clinical and Translational Science|January 30, 2020
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Nick Dand, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasisNick Dand, Michael Duckworth, David Baudry, et al.
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
Pageof 1